ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia (original) (raw)

Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with Dementia

Anne Bailey

Drugs & Aging, 2002

View PDFchevron_right

Elderly Patients With Dementia-Related Symptoms of Severe Agitation and Aggression: Consensus Statement on Treatment Options, Clinical Trials Methodology, and Policy

George Grossberg

The Journal of Clinical Psychiatry, 2008

View PDFchevron_right

The treatment of behavioral disturbances and psychosis associated with dementia

Gerald Maguire

Psychiatria Polska, 2016

View PDFchevron_right

Elderly Patients With Dementia-Related Symptoms of Severe Agitation and Aggression

Murray Raskind

The Journal of Clinical Psychiatry, 2008

View PDFchevron_right

Treatment of agitation in dementia

Anton Porsteinsson

New directions for mental health services, 1997

View PDFchevron_right

Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review

Annie Guerin

Journal of Alzheimer's Disease

View PDFchevron_right

Pharmacological Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) in Nursing Homes: Development of Practice Recommendations in a Swiss Canton

Olivier Bugnon

Journal of the American Medical Directors Association, 2008

View PDFchevron_right

Alternative pharmacological treatment options for agitation in Alzheimer’s disease

B. Imbimbo

Geriatric Care, 2015

View PDFchevron_right

A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD)

Maree Donna Simpson

Pharmacy

View PDFchevron_right

Prescribing patterns for psychotic and behavioural symptoms in dementia: a national survey

Elizabeth Brooks

Psychiatric Bulletin, 2002

View PDFchevron_right

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease

B. Imbimbo

Expert opinion on pharmacotherapy, 2015

View PDFchevron_right

Antidepressants for agitation and psychosis in patients with dementia

quynh bui

American family physician, 2012

View PDFchevron_right

Neuropsychiatric symptoms in dementia: Importance and treatment considerations Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College Introduction: Frequency and importance of dementia

Sally Sharp

View PDFchevron_right

Managing agitation in Alzheimer's disease and related disorders

Linda Hershey MD, PhD FAAN FANA

View PDFchevron_right

Don't use antipsychotics routinely to treat agitation and aggression in people with dementia

Anne Corbett

BMJ (Clinical research ed.), 2014

View PDFchevron_right

Clinical Trial Studies of Antipsychotics during Symptomatic Presentations of Agitation and/or Psychosis in Alzheimer’s Dementia: A Systematic Review

Maree Donna Simpson

Psychiatry international, 2023

View PDFchevron_right

Role of antipsychotics for treating behavioral and psychological symptoms of dementia

Kai Zhen Yap

World Journal of Pharmacology, 2014

View PDFchevron_right

Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis

Itthipol Tawankanjanachot

British journal of clinical pharmacology, 2018

View PDFchevron_right

Paradoxical side effect in treatment with antipsychotics for aggression/agitation and psychosis in dementia: case-series

Tudor Florea

BULLETIN OF INTEGRATIVE PSYCHIATRY, 2020

View PDFchevron_right

Can pharmacotherapy effectively reduce Alzheimer’s related agitation?

Madia LOZUPONE

Expert Opinion on Pharmacotherapy, 2020

View PDFchevron_right

Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates

Nikola Fajkis

CNS Drugs

View PDFchevron_right

Agitation in Nursing Home Residents With Dementia (VIDEANT Trial): Effects of a Cluster-Randomized, Controlled, Guideline Implementation Trial

Hans Gutzmann

Journal of the American Medical Directors Association, 2013

View PDFchevron_right

Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials

Cornelius Katona

The British Journal of Psychiatry, 2014

View PDFchevron_right

Agitation in patients with dementia: a systematic review of epidemiology and association with severity and course

Ann Hartry

International Psychogeriatrics

View PDFchevron_right

Neuropsychiatric symptoms in dementia: Importance and treatment considerations

Sally Sharp

International Review of Psychiatry, 2008

View PDFchevron_right

Treatment of Dementia-Associated Agitation With Gabapentin

David Roane

The Journal of Neuropsychiatry and Clinical Neurosciences, 2000

View PDFchevron_right

Rethinking antipsychotic use in dementia: a literature review on efficacy, safety, and alternatives

Omar Basubrain

2024

View PDFchevron_right

Management of Neuropsychiatric Symptoms in People with Dementia

Anne Corbett

CNS Drugs, 2010

View PDFchevron_right

Psychiatric symptoms of dementia: Treatable, but no silver bullet

Barbara Messinger-Rapport

Cleveland Clinic Journal of Medicine, 2009

View PDFchevron_right

Antipsychotics Continue to Have a Place in the Management of Difficult Behavior Problems in Patients With Dementia

George Grossberg

Journal of the American Medical Directors Association, 2013

View PDFchevron_right

Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel

Helen Kales

Journal of the American Geriatrics Society, 2014

View PDFchevron_right

A preclinical screen to evaluate pharmacotherapies for the treatment of agitation in dementia

Deaglan Page

Behavioural Pharmacology, 2017

View PDFchevron_right